The headline EPS miss and wider GAAP loss guidance are likely to pressure the stock near-term, but the maintained revenue/adjusted EBITDA guidance and strong LUMRYZ launch provide a floor. Watch for the Q3 2026 trajectory of LUMRYZ and any updates on the alixorexton phase 2 idiopathic hypersomnia data expected by year-end.
ALKS drugs
ALKS drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 28 $50.50entry
- T+1 · 4mo ago −4.28%α −2.74% · $48.34
- T+5 · 4mo ago −1.92%α −4.19% · $49.53
- T+20 · 3mo ago −2.55%α −5.94% · $49.21
- T+60 · 27d ago −13.90%α −18.25% · $43.48
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Alkermes reported Q2 2026 revenue of $496.0M (+27% YoY), driven by the Avadel acquisition adding LUMRYZ ($96.6M). GAAP net income was $0.5M ($0.00 EPS), a sharp miss vs consensus of $0.29, due to acquisition-related costs and a $26.4M CVR fair-value charge. Full-year guidance was maintained for revenue and adjusted EBITDA, but GAAP net loss guidance was widened to ($95M)-($115M) from ($70M)-($90M) due to the CVR charge. The CEO transition to Blair Jackson on August 1 is a neutral event. The stock will likely trade on the EPS miss and wider GAAP loss, offset by solid LUMRYZ uptake and maintained core guidance.
Key Financial Metrics
Key Facts
- Q2 2026 total revenue $496.0M, up 27% YoY from $390.7M
- GAAP net income $0.5M ($0.00 diluted EPS) vs consensus $0.29, a 100% miss
- LUMRYZ contributed $96.6M in its first full quarter post-Avadel acquisition
- Full-year 2026 revenue guidance maintained at $1.73B-$1.84B; adjusted EBITDA maintained at $370M-$410M
- GAAP net loss guidance widened to ($95M)-($115M) from ($70M)-($90M) due to a $26.4M CVR fair-value charge
- Blair Jackson to become CEO on August 1, 2026; Richard Pops remains Chairman
- Cash and investments grew to $691.6M from $538.2M at Q1 2026 end
Financial Impact
GAAP EPS miss of $0.29 vs consensus; GAAP net loss guidance widened by ~$25M at midpoint
Risk Factors
- GAAP net loss guidance widened due to non-cash CVR charge, which may spook momentum investors
- Integration of Avadel and LUMRYZ commercial execution remain key execution risks
- CEO transition could introduce near-term organizational uncertainty
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-318844 |
| Document: alks-20260728.htm | 0001193125-26-318844 |
| Document: alks-ex99_2.htm | 0001193125-26-318844 |
| Document: 0001193125-26-318844-index-headers.html | 0001193125-26-318844 |
| Document: 0001193125-26-318844-index.html | 0001193125-26-318844 |
| Document: 0001193125-26-318844.txt | 0001193125-26-318844 |
| 8-K Data (Synthetic) | 0001193125-26-318844 |
Track record
23 reports on ALKS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $46.98 Now $46.53 −0.96% settles Feb 10
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $44.54 Now $46.53 +4.47% settles Feb 3
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $45.89 Now $46.53 +1.39% settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $45.69 Now $46.53 +1.84% settles Feb 1
- Sep 21, 20268w ago 8-K Bullish 6/10 Entry $44.00 Now $46.53 +5.76% settles Dec 15
- Sep 16, 20268w ago 8-K Neutral 2/10 Entry $46.07 Now $46.53 +1.00% settles Dec 10
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $46.10 Now $46.53 +0.93% settles Dec 1
- Aug 3, 202615w ago Insider Cluster Bearish 4/10 Entry $49.67 to $44.32 Now $46.53 +6.32% ▲ +10.77% +11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 2/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 3/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers